.png){kind=icon}
Return
The PROTACtable genome
.png){kind=icon}
PRE
AI
DOI：10.1038/s41573-021-00245-x.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Targeted protein degradation by proteolysis-targeting chimeras (PROTACs) is attracting substantial interest as a therapeutic modality that could circumvent some limitations of traditional small-molecule drugs. This article presents a systematic approach to assessing the PROTAC tractability (PROTACtability) of protein targets, which could support decision-making on whether a particular target may be amenable to modulation using a PROTAC. Proteolysis-targeting chimeras (PROTACs) are an emerging drug modality that may offer new opportunities to circumvent some of the limitations associated with traditional small-molecule therapeutics. By analogy with the concept of the 'druggable genome', the question arises as to which potential drug targets might PROTAC-mediated protein degradation be most applicable. Here, we present a systematic approach to the assessment of the PROTAC tractability (PROTACtability) of protein targets using a series of criteria based on data and information from a diverse range of relevant publicly available resources. Our approach could support decision-making on whether or not a particular target may be amenable to modulation using a PROTAC. Using our approach, we identified 1,067 proteins of the human proteome that have not yet been described in the literature as PROTAC targets that offer potential opportunities for future PROTAC-based efforts.
Keywords:
SELECTIVE DEGRADATION
PROTEIN-DEGRADATION
UBIQUITIN LIGASES
SLC TRANSPORTERS
TARGETS
DISCOVERY
DEGRADER
IDENTIFICATION
COMPLEX
DESIGN
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
101.8
Papers:
5.1K
Citations:
5.3W
Organization
Cited Papers
ShareSaveShareSaveBAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.png)
NATURE CHEMICAL BIOLOGY
OAAI
NATURE CHEMICAL BIOLOGYIF13.7
OAAIShareSaveSmall-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugsEBIOMEDICINEOAAI
EBIOMEDICINEIF10.8
OAAIShareSaveOpen Targets Platform: supporting systematic drug-target identification and prioritisationNUCLEIC ACIDS RESEARCHOAAI
NUCLEIC ACIDS RESEARCHIF13.1
OAAIShareSaveShareSaveShareSave
View more